An International Autism Portfolio Analysis By United States (IACC-NIH), United Kingdom (Autistica) and Canada (Canadian Government)

Background: In this talk, the Office of Autism Research Coordination (OARC) of the U.S. National Institutes of Health (NIH), Autistica of the U.K., and the Canadian Government will present findings from a ground-breaking International Portfolio Analysis that describes autism research investments spanning government and private funders in the U.S., U.K., and Canada.

OARC/NIH manages the Interagency Autism Coordinating Committee (IACC) a federal advisory body that provides advice to the U.S. government on issues related to ASD. OARC conducts an annual portfolio analysis of U.S. research projects to help guide the IACC’s strategic planning efforts. Autistica is the national autism research charity in the UK. The Canadian Institutes of Health Research (CIHR) Institute of Neurosciences, Mental Health and Addiction (INMHA) supports research on biomedical, clinical, health services, and population research related to the neurosciences, mental health, and addiction.

These three international partners collected and analyzed data from research projects funded by government and private funders in their respective countries and analyzed it according to the seven general categories of research described in the IACC Strategic Plan for ASD.

Objectives: By taking an international perspective centered on universal research topic areas, the portfolio analysis presented in this talk should improve knowledge of international research efforts in the seven research areas adapted from the IACC Strategic Plan and identify potential gaps or areas of opportunity for future research endeavors and collaborations. The international partners plan to continue the analysis as an annual exercise and aim to encourage participation from more countries to demonstrate global progress in the field of autism research.

Methods: N/A

Results: N/A

Conclusions: N/A